Chubb Short-Term Borrowings remained flat by 0.0% to $1.50B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 87.4%, from $800.00M to $1.50B. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $999.00M | $1.47B | $1.47B | $1.48B | $475.00M | $0.00 | $699.00M | $700.00M | $1.46B | $2.27B | $1.55B | $1.57B | $800.00M | $0.00 | $1.50B | $1.50B | $1.50B |
| QoQ Change | — | +47.5% | +0.0% | +0.1% | -67.8% | -100.0% | — | +0.1% | +108.6% | +55.1% | -31.4% | +1.2% | -49.1% | -100.0% | — | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -52.5% | -100.0% | -52.6% | -52.5% | +207.4% | — | +122.2% | +124.4% | -45.2% | -100.0% | -3.5% | -4.6% | +87.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.